AKESO INC
HKEX: 9926 (AKESO)
Kemas kini terakhir: 1 jam lalu93.60
-1.45 (-1.53%)
| Penutupan Terdahulu | 95.05 |
| Jumlah Dagangan | 7,152,000 |
| Harga / Pendapatan (P/E Ke hadapan) | 57.47 |
| Harga / Jualan (P/S) | 21.57 |
| Harga / Buku (P/B) | 8.83 |
| Julat 52 Minggu |
| Margin Keuntungan | -24.23% |
| Margin Operasi (TTM) | -31.62% |
| EPS Cair (TTM) | -0.660 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 29.40% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 58.52% |
| Nisbah Semasa (MRQ) | 5.15 |
| Aliran Tunai Operasi (OCF TTM) | -527.62 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.11 B |
| Pulangan Atas Aset (ROA TTM) | -4.16% |
| Pulangan Atas Ekuiti (ROE TTM) | -8.89% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | AKESO | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 4.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.33 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| AKESO | - | - | - | 8.83 |
| WUXI BIO | - | - | - | 3.64 |
| SBP GROUP | - | 1.15% | - | 2.63 |
| INNOVENT BIO | - | - | - | 7.57 |
| ASCENTAGE | - | - | - | 19.80 |
| KEYMED BIO-B | - | - | - | 5.00 |
|
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company has developed more than 50 drug candidates, including 15 bispecific antibody/multispecific antibody/bispecific antibody ADC/ADC/TCE drugs, with 27 drugs in clinical development. The majority of the company's revenue is derived from Mainland China, and it also has its presence in the USA and Other regions. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Large Growth |
| % Dimiliki oleh Orang Dalam | 24.58% |
| % Dimiliki oleh Institusi | 28.47% |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |